[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350778-105":59,"doc-detail-350778-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","treatment-outcomes-in-head-and-neck-cancer-presenting-with-synchronous-primaries-case-series","Treatment outcomes in head and neck cancer presenting with synchronous primaries - case series","","Head and neck cancer accompanied by synchronous primary cancers is rare, and limited evidence exists on treatment modalities, outcomes, and combined-treatment toxicities. A retrospective screening identified patients treated with head and neck cancer radiotherapy in the Saint Luke’s Radiation Oncology Network from July 2017 to July 2024. From 2,971 radiotherapy-treated cases, 48 met inclusion. Overall survival and completion of definitive therapy were assessed, including cases with overlapping radiotherapy fields, to evaluate curative feasibility and acceptable toxicity.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/treatment-outcomes-in-head-and-neck-cancer-presenting-with-synchronous-primaries-case-series/350778/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/treatment-outcomes-in-head-and-neck-cancer-presenting-with-synchronous-primaries-case-series/350778.png","ImageObject",300,407,{"name":92,"@type":93},"CatatanPagi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"How was a synchronous primary cancer defined in this case series?","Question",{"text":112,"@type":113},"A synchronous primary cancer was defined as an anatomically separate cancer, not a possible metastasis of the first primary, and diagnosed within six months of the first primary cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What proportion of head and neck cancer radiotherapy patients met the inclusion criteria?",{"text":117,"@type":113},"Of 2,971 head and neck cancer patients treated with radiotherapy, 48 patients (2%) met the inclusion criteria for synchronous primary cancers.",{"name":119,"@type":110,"acceptedAnswer":120},"What was the overall survival for patients who completed definitive treatment for both cancers?",{"text":121,"@type":113},"Patients who completed definitive treatment for both cancers had a median overall survival of 30.2 months versus 5.5 months for those who did not (p \u003C 0.001).",{"name":123,"@type":110,"acceptedAnswer":124},"Can simultaneous radiotherapy with overlapping fields be completed with acceptable toxicity?",{"text":125,"@type":113},"Simultaneous radiotherapy for both cancers could be completed by most patients, and the study concludes that it can be performed with acceptable toxicity rates even when radiation fields overlap.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},350778,1790624482,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":19,"preview_urls":149},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","REPORTS OF PRACTICAL  \nONCOLOGY AND RADIOTHERAPY  \n© 2026 Greater Poland Cancer Centre. Published by Via Medica.  \nAll rights reserved. e-ISSN 2083–4640  \nISSN 1507–1367  \nISSN: 1507–1367  \nRESEARCH PAPER  \nReports of Practical Oncology and Radiotherapy 2026, Volume 31, Number 4, pages: 469–478  \nDOI: 10.5603/rpor.112208  \nSubmitted: 26.07.2025  \nAccepted: 15.04.2026  \nTreatment outcomes in head and neck cancer presenting with synchronous primaries—case series  \nLiam O’Connell, Niall O’Dwyer, Frances Duane, Sinead Brennan, John Armstrong, Nazmy El Beltagi, Oleksandr Boychak, Dymphna McGettigan, Orla McArdle  \nRadiation Oncology, St. Luke’s Hospital, Rathgar, Ireland  \nABSTRACT  \nBackground: Head and neck cancer with synchronous primary cancers is rare. There is a paucity of data on HNC with SPC regarding treatment modalities, outcomes, and combined treatment toxicities, creating a challenge for treating clinicians. Materials and methods: We retrospectively screened patients who received head and neck cancer radiotherapy in the Saint Luke’s Radiation Oncology Network from July 2017 to July 2024. A synchronous primary cancer was defined as anatomically separate, not a possible metastasis of the first primary cancer and diagnosed within six months of the first primary cancer. Results: We screened 2,971 HNC patients who underwent radiotherapy of which 48 (2%) patients met the inclusion criteria. The median follow-up was 21.9 months and median age was 65 years. The most common SPC sites were lung (46%), oesophageal (13%), then prostate, colon and thyroid (all 6%). The median overall survival for all patients was 28 months. Forty-two (88%) patients completed definitive treatment for both cancers. The median overall survival of patients who completed definitive treatment for both cancers was 30.2 months vs. 5.5 months among patients who did not (p \u003C 0.001). Ten patients had simultaneous radiotherapy to both cancers with overlapping radiotherapy fields and nine of them finished definitive treatment to both cancers. Conclusions: Patients with HNC and a synchronous primary can be treated curatively to both cancers with a median overall survival of over 2 years. Simultaneous radiotherapy for both cancers can be completed with acceptable toxicity rates even in the setting of overlapping radiation fields.  \nKeywords: head and neck cancer; radiotherapy Rep Pract Oncol Radiother 2026;31(4):469–478  \nIntroduction  \nDefinitive radiotherapy for head and neck cancer (HNC) is associated with high rates of toxicity. Grade 3–4 toxicity rates for this patient cohort have been reported as follows: mucositis (45%), dysphagia (40%), dermatitis (22%) and xerostomia (39%)  \n[1] . On systematic review of over 450,000 patients, Coca-Pelaz et al. [2] showed an incidence of synchronous primary cancers (SPC) in patients with  \nHNC of 5.3%, with the most common sites being another HNC followed by lung and oesophageal cancer. Chen et al. [3] reviewed 60 HNC patients with a synchronous oesophageal primary who completed simultaneous chemoradiotherapy to both sites and showed similar rates of mucositis (33%) and dermatitis (28%) as previously stated for HNC radiotherapy alone [1] .  \nHNC with SPC, defined as both primary cancers being diagnosed within six months, is less  \nAddress for correspondence: Liam O’Connell, Radiation Oncology, St. Luke’s Hospital, Rathgar, Dublin 6, D06 HH36, Ireland,  \ne-mail: [liamjoc@hotmail.co.uk](liamjoc@hotmail.co.uk)  \nThis article is available in open access under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International license (CC BY-NC-ND 4.0), which permits users to download and share the article with others, provided that they credit the authors and the publisher, do not alter the article in any way, and do not use it commercially.  \n[https://journals.viamedica.pl/rpor](https://journals.viamedica.pl/rpor)  \n469  \ncommon. Yamashita et al. [4] reviewed 434 patients with newly diagnosed HNC and found a rate ","cbCaiqJlhFxFxm9V","https://ap.wps.com/l/cbCaiqJlhFxFxm9V","pdf",525593,"English","# Introduction\n## Materials and methods\n## Results\n## Conclusions","[{\"question\":\"How was a synchronous primary cancer defined in this case series?\",\"answer\":\"A synchronous primary cancer was defined as an anatomically separate cancer, not a possible metastasis of the first primary, and diagnosed within six months of the first primary cancer.\"},{\"question\":\"What proportion of head and neck cancer radiotherapy patients met the inclusion criteria?\",\"answer\":\"Of 2,971 head and neck cancer patients treated with radiotherapy, 48 patients (2%) met the inclusion criteria for synchronous primary cancers.\"},{\"question\":\"What was the overall survival for patients who completed definitive treatment for both cancers?\",\"answer\":\"Patients who completed definitive treatment for both cancers had a median overall survival of 30.2 months versus 5.5 months for those who did not (p \\u003c 0.001).\"},{\"question\":\"Can simultaneous radiotherapy with overlapping fields be completed with acceptable toxicity?\",\"answer\":\"Simultaneous radiotherapy for both cancers could be completed by most patients, and the study concludes that it can be performed with acceptable toxicity rates even when radiation fields overlap.\"}]","Treatment outcomes in head and neck cancer presenting with synchronous primaries - case series | PDF",1790091033,25,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86830ac60d36e6d77d30ee92ff53c46c.webp",983,1390,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a75ee9ff9c05c2992bb92d45c981d70f.webp",982,1389,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8f0a3c78fd69a614e69c8171f6467d2.webp",981,1387,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7aaf8159326810c60a2a8e53bc2acfe2.webp",980,1386]